Investigators have published and presented exciting clinical results in dozens of treated patients with sickle cell disease.

CRISPR Prime Time? FDA Advisory Committee Evaluates Vertex Exa-Cel Therapy for Sickle Cell Disease

The treatment, called exa-cel and administered with a single infusion, was as created by Boston-based Vertex Pharmaceuticals and CRISPR Therapeutics, which is headquartered in Switzerland but has most of its employees in Mass.

Patients with sickle cell disease urge FDA to greenlight landmark gene-editing treatment

Advisers to the Food and Drug Administration meet Tuesday to review the first treatment of human disease using the gene-editing technique CRISPR. The agency has a December deadline to make a decision.

A landmark gene-editing treatment for sickle cell disease moves closer to reality

Fitchburg-raised Ruben Seyde never imagined he would be where he is today, after being known as "a pothead" in high school. Nowadays, the Twin Cities native is peddling drugs legally as the founder and CEO of Delivered Inc.

Taking green from gray to white

Police said they were told that two men wearing gray jogging suites with hoodies over their heads pulled up next to a delivery truck in a gray Infiniti 4-door.

Memphis police looking for suspects they say stole pharmaceutical products, COVID supplies from delivery truck

An ABC delivery driver was robbed of COVID supplies and pharmaceutical products at an East Memphis Walgreens, police say. At 9 a.m. Friday, Memphis Police responded to 6310 Poplar Avenue regarding a robbery.

Suspects rob ABC delivery driver, steal COVID supplies

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

A new cure for sickle cell disease may be coming. Health advisers will review it next week

The only cure for painful sickle cell disease today is a bone marrow transplant. But soon there may be a new cure that attacks the disorder at its genetic source.

Highlighted among 200 groundbreaking innovations, FeaturePrint is recognized in the AI category  BELLEVUE, Wash., Oct. 24, 2023 /PRNewswire/ -- Alitheon,

Alitheon FeaturePrint® Named Among TIME Best Inventions of 2023

Crinetics Pharmaceuticals Inc’s recent filing unveils that its Chief Medical Officer Krasner Alan Seth unloaded Company’s shares for reported $0.21 million on Oct 17. In the deal valued at $30.00 per share,7,000 shares were sold. As a result of this transaction, Krasner Alan Seth now holds 43,210 shares worth roughly $1.27 million.

Analysts review Crinetics Pharmaceuticals Inc’s rating

Grays Pharmaceuticals

HackerNoon.com hosted Startups of The Year to highlight the backbone of the future - tech startups!

GRAYS PHARMACEUTICALS

grayspharmaceuticals.com

employees

Since n.d.

COMPANY RANKING

GRAYS PHARMACEUTICALS

EVERGREEN INDEX #1809

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #Grays Pharmaceuticals

Grays Pharmaceuticals WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!

GRAYS PHARMACEUTICALS

grayspharmaceuticals.com

employees

Since n.d.

COMPANY RANKING

GRAYS PHARMACEUTICALS

EVERGREEN INDEX #1809

RELATED COMPANIESRANK

HACKERNOON STORIES ON GRAYS PHARMACEUTICALS

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #Grays Pharmaceuticals

Grays Pharmaceuticals WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!